MiR-339 and especially miR-766 reactivate the expression of tumor suppressor genes in colorectal cancer cell lines through DNA methyltransferase 3B gene inhibition

References

• Damnjanovic I, Kocic G, Najman S, Stojanovic S, Stojanovic D, Veljkovic A, Conic I, Langerholc T, Pesic S. Chemopreventive potential of alpha lipoic acid in the treatment of colon and cervix cancer cell lines. Bratisl Lek Listy 2014; 115:611-6; PMID:25573726
   PubMed Web of Science ®Google Scholar
• Althoff KN, McGinnis KA, Wyatt CM, Freiberg MS, Gilbert C, Oursler KK, Rimland D, Rodriguez-Barradas MC, Dubrow R, Park LS, et al. Comparison of risk and age at diagnosis of myocardial infarction, end-stage renal disease, and non-AIDS-defining cancer in HIV-infected versus uninfected adults. Clin Infect Dis 2015; 60:627-38; PMID:25362204; http://dx.doi.org/10.1093/cid/ciu869
   PubMed Web of Science ®Google Scholar
• McGuire S. World Health Organization. Comprehensive implementation plan on maternal, infant, and young child nutrition. Geneva, Switzerland, 2014. Adv Nutr 2015; 6:134-5; PMID:25593153; http://dx.doi.org/10.3945/an.114.007781
   PubMed Web of Science ®Google Scholar
• Mendis S, Davis S, Norrving B. Organizational update: the world health organization global status report on noncommunicable diseases 2014; one more landmark step in the combat against stroke and vascular disease. Stroke 2015; 46:e121-2; PMID:25873596; http://dx.doi.org/10.1161/STROKEAHA.115.008097
   PubMed Web of Science ®Google Scholar
• Hodgson S. Mechanisms of inherited cancer susceptibility. J Zhejiang Univ Sci B 2008; 9:1-4; PMID:18196605; http://dx.doi.org/10.1631/jzus.B073001
   PubMed Web of Science ®Google Scholar
• Conlin A, Smith G, Carey FA, Wolf CR, Steele RJ. The prognostic significance of K-ras, p53, and APC mutations in colorectal carcinoma. Gut 2005; 54:1283-6; PMID:15843421; http://dx.doi.org/10.1136/gut.2005.066514
   PubMed Web of Science ®Google Scholar
• Agrawal A, Murphy RF, Agrawal DK. DNA methylation in breast and colorectal cancers. Mod Pathol 2007; 20:711-21; PMID:17464311; http://dx.doi.org/10.1038/modpathol.3800822
   PubMed Web of Science ®Google Scholar
• Ibrahim AE, Arends MJ, Silva AL, Wyllie AH, Greger L, Ito Y, Vowler SL, Huang TH, Tavaré S, Murrell A, et al. Sequential DNA methylation changes are associated with DNMT3B overexpression in colorectal neoplastic progression. Gut 2011; 60:499-508; PMID:21068132; http://dx.doi.org/10.1136/gut.2010.223602
   PubMed Web of Science ®Google Scholar
• Bariol C, Suter C, Cheong K, Ku SL, Meagher A, Hawkins N, Ward R. The relationship between hypomethylation and CpG island methylation in colorectal neoplasia. Am J Pathol 2003; 162:1361-71; PMID:12651628; http://dx.doi.org/10.1016/S0002-9440(10)63932-6
   PubMed Web of Science ®Google Scholar
• Curradi M, Izzo A, Badaracco G, Landsberger N. Molecular mechanisms of gene silencing mediated by DNA methylation. Mol Cell Biol 2002; 22:3157-73; PMID:11940673; http://dx.doi.org/10.1128/MCB.22.9.3157-3173.2002
   PubMed Web of Science ®Google Scholar
• Kanai Y, Hirohashi S. Alterations of DNA methylation associated with abnormalities of DNA methyltransferases in human cancers during transition from a precancerous to a malignant state. Carcinogenesis 2007; 28:2434-42; PMID:17893234; http://dx.doi.org/10.1093/carcin/bgm206
   PubMed Web of Science ®Google Scholar
• Nosho K, Shima K, Irahara N, Kure S, Baba Y, Kirkner GJ, Chen L, Gokhale S, Hazra A, Spiegelman D, et al. DNMT3B expression might contribute to CpG island methylator phenotype in colorectal cancer. Clin Cancer Res 2009; 15:3663-71; PMID:19470733; http://dx.doi.org/10.1158/1078-0432.CCR-08-2383
   PubMed Web of Science ®Google Scholar
• Linhart HG, Lin H, Yamada Y, Moran E, Steine EJ, Gokhale S, Lo G, Cantu E, Ehrich M, He T, et al. Dnmt3b promotes tumorigenesis in vivo by gene-specific de novo methylation and transcriptional silencing. Genes Dev 2007; 21:3110-22; PMID:18056424; http://dx.doi.org/10.1101/gad.1594007
   PubMed Web of Science ®Google Scholar
• Robertson KD, Uzvolgyi E, Liang G, Talmadge C, Sumegi J, Gonzales FA, Jones PA. The human DNA methyltransferases (DNMTs) 1, 3a and 3b: coordinate mRNA expression in normal tissues and overexpression in tumors. Nucleic Acids Res 1999; 27:2291-8; PMID:10325416; http://dx.doi.org/10.1093/nar/27.11.2291
   PubMed Web of Science ®Google Scholar
• Schmidt WM, Sedivy R, Forstner B, Steger GG, Zochbauer-Muller S, Mader RM. Progressive up-regulation of genes encoding DNA methyltransferases in the colorectal adenoma-carcinoma sequence. Mol Carcinog 2007; 46:766-72; PMID:17538945; http://dx.doi.org/10.1002/mc.20307
   PubMed Web of Science ®Google Scholar
• Roll JD, Rivenbark AG, Jones WD, Coleman WB. DNMT3b overexpression contributes to a hypermethylator phenotype in human breast cancer cell lines. Mol Cancer 2008; 7:15; PMID:18221536; http://dx.doi.org/10.1186/1476-4598-7-15
   PubMed Web of Science ®Google Scholar
• Metivier R, Gallais R, Tiffoche C, Le Peron C, Jurkowska RZ, Carmouche RP, Ibberson D, Barath P, Demay F, Reid G, et al. Cyclical DNA methylation of a transcriptionally active promoter. Nature 2008; 452:45-50; PMID:18322525; http://dx.doi.org/10.1038/nature06544
   PubMed Web of Science ®Google Scholar
• Landi D, Gemignani F, Naccarati A, Pardini B, Vodicka P, Vodickova L, Novotny J, Försti A, Hemminki K, Canzian F, et al. Polymorphisms within micro-RNA-binding sites and risk of sporadic colorectal cancer. Carcinogenesis 2008; 29:579-84; PMID:18192692; http://dx.doi.org/10.1093/carcin/bgm304
   PubMed Web of Science ®Google Scholar
• Friedman RC, Farh KK, Burge CB, Bartel DP. Most mammalian mRNAs are conserved targets of microRNAs. Genome Res 2009; 19:92-105; PMID:18955434; http://dx.doi.org/10.1101/gr.082701.108
   PubMed Web of Science ®Google Scholar
• Krek A, Grun D, Poy MN, Wolf R, Rosenberg L, Epstein EJ, MacMenamin P, da Piedade I, Gunsalus KC, Stoffel M, et al. Combinatorial microRNA target predictions. Nat Genet 2005; 37:495-500; PMID:15806104; http://dx.doi.org/10.1038/ng1536
   PubMed Web of Science ®Google Scholar
• Freedman JE, Tanriverdi K. Defining miRNA targets: balancing simplicity with complexity. Circulation 2013; 127:2075-7; PMID:23625958; http://dx.doi.org/10.1161/CIRCULATIONAHA.113.003058
   PubMed Web of Science ®Google Scholar
• Yanaihara N, Caplen N, Bowman E, Seike M, Kumamoto K, Yi M, Stephens RM, Okamoto A, Yokota J, Tanaka T, et al. Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell 2006; 9:189-98; PMID:16530703; http://dx.doi.org/10.1016/j.ccr.2006.01.025
   PubMed Web of Science ®Google Scholar
• Lamy P, Andersen CL, Dyrskjot L, Torring N, Orntoft T, Wiuf C. Are microRNAs located in genomic regions associated with cancer? Br J Cancer 2006; 95:1415-8; PMID:17003783; http://dx.doi.org/10.1038/sj.bjc.6603381
   PubMed Web of Science ®Google Scholar
• Duursma AM, Kedde M, Schrier M, le Sage C, Agami R. miR-148 targets human DNMT3b protein coding region. RNA 2008; 14:872-7; PMID:18367714; http://dx.doi.org/10.1261/rna.972008
   PubMed Web of Science ®Google Scholar
• Teimoori-Toolabi L, Azadmanesh K, Zeinali S. Selective suicide gene therapy of colon cancer cell lines exploiting fibroblast growth factor 18 promoter. Cancer Biother Radiopharm 2010; 25:105-16; PMID:20187803; http://dx.doi.org/10.1089/cbr.2009.0643
   PubMed Web of Science ®Google Scholar
• Teimoori-Toolabi L, Hashemi S, Azadmanesh K, Eghbalpour F, Safavifar F, Khorramizadeh MR. Silencing the wild-type and mutant K-ras increases the resistance to 5-flurouracil in HCT-116 as a colorectal cancer cell line. Anti-cancer Drugs 2015; 26:187-96; PMID:25325304; http://dx.doi.org/10.1097/CAD.0000000000000175
   PubMed Web of Science ®Google Scholar
• Lao VV, Grady WM. Epigenetics and colorectal cancer. Nat Rev Gastroenterol Hepatol 2011; 8:686-700; PMID:22009203; http://dx.doi.org/10.1038/nrgastro.2011.173
   PubMed Web of Science ®Google Scholar
• Yun J, Song SH, Park J, Kim HP, Yoon YK, Lee KH, Han SW, Oh DY, Im SA, Bang YJ, et al. Gene silencing of EREG mediated by DNA methylation and histone modification in human gastric cancers. Lab Invest 2012; 92:1033-44; PMID:22508389; http://dx.doi.org/10.1038/labinvest.2012.61
   PubMed Web of Science ®Google Scholar
• Nosho K, Shima K, Irahara N, Kure S, Baba Y, Kirkner GJ, Chen L, Gokhale S, Hazra A, Spiegelman D, et al. DNMT3B expression might contribute to CpG island methylator phenotype in colorectal cancer. Clin Cancer Res 2009; 15:3663-71; PMID:19470733; http://dx.doi.org/10.1158/1078-0432.CCR-08-2383
   PubMed Web of Science ®Google Scholar
• Sandhu R, Rivenbark AG, Coleman WB. Loss of post-transcriptional regulation of DNMT3b by microRNAs: a possible molecular mechanism for the hypermethylation defect observed in a subset of breast cancer cell lines. Int J Oncol 2012; 41:721-32; PMID:22664488; http://dx.doi.org/10.3892/ijo.2012.1505
   PubMed Web of Science ®Google Scholar
• Fabbri M, Calin GA. Epigenetics and miRNAs in human cancer. Adv Genet 2010; 70:87-99; PMID:20920746; http://dx.doi.org/10.1016/B978-0-12-380866-0.60004-6
   PubMed Web of Science ®Google Scholar
• Garzon R, Liu S, Fabbri M, Liu Z, Heaphy CE, Callegari E, Schwind S, Pang J, Yu J, Muthusamy N, et al. MicroRNA-29b induces global DNA hypomethylation and tumor suppressor gene reexpression in acute myeloid leukemia by targeting directly DNMT3A and 3B and indirectly DNMT1. Blood 2009; 113:6411-8; PMID:19211935; http://dx.doi.org/10.1182/blood-2008-07-170589
   PubMed Web of Science ®Google Scholar
• Robaina MC, Mazzoccoli L, Arruda VO, Reis FR, Apa AG, de Rezende LM, Klumb CE. Deregulation of DNMT1, DNMT3B and miR-29s in Burkitt lymphoma suggests novel contribution for disease pathogenesis. Exp Mol Pathol 2015; 98:200-7; PMID:25746661; http://dx.doi.org/10.1016/j.yexmp.2015.03.006
   PubMed Web of Science ®Google Scholar
• Krek A, Grün D, Poy MN, Wolf R, Rosenberg L, Epstein EJ, MacMenamin P, da Piedade I, Gunsalus KC, Stoffel M. Combinatorial microRNA target predictions. Nature genetics 2005; 37:495-500; PMID:15806104; http://dx.doi.org/10.1038/ng1536
   PubMed Web of Science ®Google Scholar
• Hlady RA, Novakova S, Opavska J, Klinkebiel D, Peters SL, Bies J, Hannah J, Iqbal J, Anderson KM, Siebler HM, et al. Loss of Dnmt3b function upregulates the tumor modifier Ment and accelerates mouse lymphomagenesis. J Clin Invest 2012; 122:163-77; PMID:22133874; http://dx.doi.org/10.1172/JCI57292
   PubMed Web of Science ®Google Scholar
• Silva AL, Dawson SN, Arends MJ, Guttula K, Hall N, Cameron EA, Huang TH, Brenton JD, Tavaré S, Bienz M, et al. Boosting Wnt activity during colorectal cancer progression through selective hypermethylation of Wnt signaling antagonists. BMC Cancer 2014; 14:891; PMID:25432628; http://dx.doi.org/10.1186/1471-2407-14-891
   PubMed Web of Science ®Google Scholar
• Zhang W, Dahlberg JE, Tam W. MicroRNAs in tumorigenesis: a primer. Am J Pathol 2007; 171:728-38; PMID:17724137; http://dx.doi.org/10.2353/ajpath.2007.070070
   PubMed Web of Science ®Google Scholar
• Azizi M, Teimoori-Toolabi L, Arzanani MK, Azadmanesh K, Fard-Esfahani P, Zeinali S. MicroRNA-148b and microRNA-152 reactivate tumor suppressor genes through suppression of DNA methyltransferase-1 gene in pancreatic cancer cell lines. Cancer Biol Ther 2014; 15:419-27; PMID:24448385; http://dx.doi.org/10.4161/cbt.27630
   PubMed Web of Science ®Google Scholar
• Hodge DR, Peng B, Pompeia C, Thomas S, Cho E, Clausen PA, Marquez VE, Farrar WL. Epigenetic silencing of manganese superoxide dismutase (SOD-2) in KAS 6/1 human multiple myeloma cells increases cell proliferation. Cancer Biol Ther 2005; 4:585-92; PMID:15908783; http://dx.doi.org/10.4161/cbt.4.5.1704
   PubMed Web of Science ®Google Scholar
• Rajendran G, Shanmuganandam K, Bendre A, Muzumdar D, Goel A, Shiras A. Epigenetic regulation of DNA methyltransferases: DNMT1 and DNMT3B in gliomas. J neuro-oncol 2011; 104:483-94; PMID:21229291; http://dx.doi.org/10.1007/s11060-010-0520-2
   PubMed Web of Science ®Google Scholar
• Taniguchi H, Yamamoto H, Hirata T, Miyamoto N, Oki M, Nosho K, Adachi Y, Endo T, Imai K, Shinomura Y. Frequent epigenetic inactivation of Wnt inhibitory factor-1 in human gastrointestinal cancers. Oncogene 2005; 24:7946-52; PMID:16007117; http://dx.doi.org/10.1038/sj.onc.1208910
   PubMed Web of Science ®Google Scholar
• Fabbri M, Garzon R, Cimmino A, Liu Z, Zanesi N, Callegari E, Liu S, Alder H, Costinean S, Fernandez-Cymering C, et al. MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B. Pro Natl Acad Sci U S A 2007; 104:15805-10; PMID:17890317; http://dx.doi.org/10.1073/pnas.0707628104
   PubMed Web of Science ®Google Scholar
• Li Y, Zhao W, Bao P, Li C, Ma XQ, Chen LA. miR-339-5p inhibits cell migration and invasion and may be associated with the tumor-node-metastasis staging and lymph node metastasis of non-small cell lung cancer. Oncol Lett 2014; 8:719-25; PMID:25009651; http://dx.doi.org/10.3892/ol.2014.2165
   PubMed Web of Science ®Google Scholar
• Ahmed D, Eide PW, Eilertsen IA, Danielsen SA, Eknaes M, Hektoen M, Lind GE, Lothe RA. Epigenetic and genetic features of 24 colon cancer cell lines. Oncogenesis 2013; 2:e71; PMID:24042735; http://dx.doi.org/10.1038/oncsis.2013.35
   PubMed Web of Science ®Google Scholar
• Smiraglia DJ, Rush LJ, Fruhwald MC, Dai Z, Held WA, Costello JF, Lang JC, Eng C, Li B, Wright FA, et al. Excessive CpG island hypermethylation in cancer cell lines versus primary human malignancies. Hum Mol Genet 2001; 10:1413-9; PMID:11440994; http://dx.doi.org/10.1093/hmg/10.13.1413
   PubMed Web of Science ®Google Scholar
• Inui M, Martello G, Piccolo S. MicroRNA control of signal transduction. Nat Rev Mol Cell Biol 2010; 11:252-63; PMID:20216554; http://dx.doi.org/10.1038/nrm2868
   PubMed Web of Science ®Google Scholar
• Bueno MJ, Perez de Castro I, Malumbres M. Control of cell proliferation pathways by microRNAs. Cell Cycle 2008; 7:3143-8; PMID:18843198; http://dx.doi.org/10.4161/cc.7.20.6833
   PubMed Web of Science ®Google Scholar